Godrej Agrovet Limited — PPTs, 01-05-2026: Investor Presentation

Godrej Agrovet reported a robust FY26, with revenue up 9.1% to ₹10,233 Cr and PAT rising 13.9% to ₹440 Cr (excluding non-recurring items), marking all-time high profitability. Animal Nutrition saw strong volume growth (+12% YoY), especially cattle feed (+18%), boosting segment results. Oil Palm had a landmark year, with segment results soaring 67.9% on double-digit volume growth and favorable pricing. Astec LifeSciences achieved EBITDA break-even, marking a significant turnaround. However, Crop Care faced challenges from adverse weather, and Dairy margins were pressured by high procurement costs.

Strategically, the company is digitally transforming, with SAP S/4HANA Wave 1 live and Wave 2 targeted for FY27 to boost efficiency. Godrej Foods is shifting to branded businesses for improved earnings. Recent developments include new Crop Care product launches (Takai, Ashitaka). ROCE improved to 20% due to optimized working capital. Management expects recovery in Crop Care and sustained profitable growth for Astec, supported by the digital roadmap.